Complement factor H polymorphism in age-related macular degeneration

…, JP SanGiovanni, SM Mane, ST Mayne, MB Bracken… - Science, 2005 - science.org
Age-related macular degeneration (AMD) is a major cause of blindness in the elderly. We
report a genome-wide screen of 96 cases and 50 controls for polymorphisms associated with …

[HTML][HTML] A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: results of the Second National Acute Spinal Cord …

MB Bracken, MJ Shepard, WF Collins… - … England Journal of …, 1990 - Mass Medical Soc
Studies in animals indicate that methylprednisolone and naloxone are both potentially
beneficial in acute spinal-cord injury, but whether any treatment is clinically effective remains …

[PDF][PDF] International standards for neurological and functional classification of spinal cord injury

FM Maynard, MB Bracken, G Creasey… - Spinal …, 1997 - ubccriticalcaremedicine.ca
The spinal cord is the major conduit through which motor and sensory information travels
between brain and body. The spinal cord contains longitudinally oriented spinal tracts (white …

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury: results of the third national acute …

MB Bracken, MJ Shepard, TR Holford, L Leo-Summers… - Jama, 1997 - jamanetwork.com
Objective. —To compare the efficacy of methylprednisolone administered for 24 hours with
methyprednisolone administered for 48 hours or tirilazad mesylate administered for 48 hours …

How to increase value and reduce waste when research priorities are set

I Chalmers, MB Bracken, B Djulbegovic, S Garattini… - The Lancet, 2014 - thelancet.com
The increase in annual global investment in biomedical research—reaching US$240 billion
in 2010—has resulted in important health dividends for patients and the public. However, …

Renal impairment and outcomes in heart failure: systematic review and meta-analysis

GL Smith, JH Lichtman, MB Bracken… - Journal of the American …, 2006 - jacc.org
Objectives : We estimated the prevalence of renal impairment in heart failure (HF) patients
and the magnitude of associated mortality risk using a systematic review of published studies. …

Clinical trials in head injury

…, A Baethmann, A Biegon, MB Bracken… - Journal of …, 2002 - liebertpub.com
Traumatic brain injury (TBI) remains a major public health problem globally. In the United
States the incidence of closed head injuries admitted to hospitals is conservatively estimated to …

Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data: results of the second National Acute Spinal Cord Injury Study

MB Bracken, MJ Shepard, WF Collins, TR Holford… - Journal of …, 1992 - thejns.org
✓ The 1-year follow-up data of a multicenter randomized controlled trial of methylprednisolone
(30 mg/kg bolus and 5.4 mg/kg/hr for 23 hours) or naloxone (5.4 mg/kg bolus and 4.0 mg/…

Efficacy of methylprednisolone in acute spinal cord injury

MB Bracken, WF Collins, DF Freeman, MJ Shepard… - Jama, 1984 - jamanetwork.com
A multicenter double-blind randomized trial was conducted to examine the efficacy of a high
dose of methylprednisolone (1,000-mg bolus and daily thereafter for ten days) compared …

Steroids for acute spinal cord injury

MB Bracken… - Cochrane Database of …, 1996 - cochranelibrary.com
Background Acute spinal cord injury is a devastating condition typically affecting young people,
mostly males. Steroid treatment in the early hours after the injury is aimed at reducing the …